Filter
7145
Filtered Results: 7145
Text search:
Monitoring
and
Evaluation
Featured
Recommendations
659
New Publications
2083
Language
Document type
No document type
4343
Studies & Reports
977
Guidelines
900
Manuals
380
Strategic & Response Plan
291
Training Material
92
Fact sheets
85
Situation Updates
45
Resource Platforms
11
Infographics
11
Brochures
8
App
1
Online Courses
1
Countries / Regions
India
289
Global
268
Kenya
231
Ethiopia
173
Uganda
156
Nepal
154
Sierra Leone
147
South Africa
146
Nigeria
138
Western and Central Europe
130
Liberia
129
Rwanda
118
Malawi
111
Zambia
109
Myanmar / Burma
109
Tanzania
108
Ghana
105
Africa
96
Bangladesh
95
Latin America and the Carribbean
86
Syria
73
Ukraine
71
Philippines
65
Congo, Democratic Republic of
64
Namibia
61
Eastern Europe
51
Lesotho
50
Cambodia
48
Indonesia
48
Zimbabwe
46
Senegal
44
South–East Asia Region
44
Haiti
42
Guinea
41
West and Central Africa
40
South Sudan
39
Mozambique
39
Germany
38
Botswana
37
East and Southern Africa
37
Middle East and North Africa
36
Burkina Faso
32
Asia
30
Russia
30
Cameroon
27
Brazil
26
Eastern Europe and Central Asia
24
Benin
23
Yemen
22
Pakistan
21
Eswatini/ Swaziland
21
Jordan
20
Afghanistan
20
Lebanon
17
Western Pacific Region
16
Venezuela
16
Mali
15
Sudan
15
Iraq
14
Madagascar
14
USA
13
Somalia
13
Thailand
13
Colombia
12
Laos
12
Vietnam
12
Tajikistan
11
Albania
10
Paraguay
9
Turkey
8
Central African Republic
8
Angola
8
Georgia
8
China
7
Argentina
7
Peru
7
Sri Lanka
7
Moldova
7
Iran
7
Côte d’Ivoire / Ivory Coast
6
Libya
6
Southern Africa
6
Kyrgyzstan
6
Portugal
6
Saudi Arabia
5
Niger
5
Egypt
5
Gambia
5
North Macedonia
5
Bhutan
5
Timor Leste/ East Timor
5
Togo
4
Chad
4
Papua New Guinea
4
Burundi
4
Mexico
4
Chile
4
Palestine
4
Armenia
4
North America
4
Spain
4
Morocco
3
Mauritania
3
Croatia
3
Honduras
3
Canada
3
Qatar
3
Estonia
3
Kazakhstan
3
Turkmenistan
3
Japan
3
United Kingdom
3
Bosnia and Herzegovina
3
Guinea-Bissau
2
Singapore
2
Vanuatu
2
Serbia
2
Ecuador
2
Bolivia
2
Greece
2
North Korea
2
Italy
2
Congo-Brazzaville
2
Romania
2
Lithuania
2
Jamaica
2
France
2
Mauritius
2
Tunisia
2
Azerbaijan
2
Israel
2
Malaysia
1
Ireland
1
Dominican Republic
1
Hungary
1
El Salvador
1
Guatemala
1
Nicaragua
1
Fiji
1
Solomon Islands
1
Poland
1
Djibouti
1
Bulgaria
1
Uruguay
1
Denmark
1
Maldives
1
Norway
1
Belarus
1
Authors & Publishers
Publication Years
Category
Countries
2810
Clinical Guidelines
558
Public Health
409
Key Resources
394
Women & Child Health
366
Capacity Building
138
Pharmacy & Technologies
72
Toolboxes
HIV
553
Mental Health
449
COVID-19
430
TB
393
Disability
275
Rapid Response
216
AMR
216
Planetary Health
215
Ebola
202
Caregiver
185
Conflict
184
NTDs
158
NCDs
119
Pharmacy
114
Natural Hazards
113
Refugee
107
Global Health Education
107
Health Financing Toolbox
56
Specific Hazards
49
Polio
41
Cholera
38
Zika
37
Social Ethics
8
Typhoon
5
Health Financing
2
South Sudan
1
The product of all this work is the Standard Treatment Guideline and Essential Medicines List of Common Medical Conditions in the Kingdom of Swaziland. These systematically developed statements are designed to assist practitioners in making decision...
South Africa has faced many challenges over the past two decades, accomplishing profound positive changes in the social structure and government of the nation. This has not yet fully translated into better health for the population, howeve...
This document provides an overview of sexual and reproductive health and rights issues that may be important for the human rights, health and well-...
Sepsis remains a leading cause of mortality and morbidity, especially during the first five days of life and in low and middle-income countries (LM...
The Guidance on National Deployment and Vaccination Planning is intended to help countries develop their plan for COVID-19 vaccine introduction.
Background paper 10
The Independent Panel for Pandemic Preparedness and Response
May 2021
Globally, 311,000 women die of cervical cancer every year, 85 percent of them
in resource limited regions of the world. To address this grave threat to women,
the WHO made a call to action in 2018, resulting in accelerated plans to improve
cervical cancer control under the elimination threshold w...
Against this background of nearly 20 years of experience of research, development and
improvement in patient safety, the role of incident and adverse event reporting, as well as the
benefits that ...
Guide for clinical case management and infection prevention and control during ameasles outbreak. This guide has been developed to reduce the high morbidity ... mortality seen in some of the current outbreaks of measles. This short guide outlines practical clinical care interventions and is derived from previously published WHO documents.
On February 29, 2020, the United States and the Taliban signed an agreement outlining a phased withdrawal of US forces from Afghanistan in exchange for Taliban commitments not to allow attacks on the US or its allies from Afghan territory. The troop...
The purpose of this document is to provide relevant information and guidelines on
coronavirus outbreaks – and in particular the novel coronavirus SARS-CoV-2 ... the
diseases it produces, COVID-19 – for pharmacists and the pharmacy workforce, both in a
primary care context (i.e. community pharmacies and primary healthcare facilities) and in
hospital settings, as well as for pharmacists working as clinical biologists in medical
analysis laboratories, for example, as clinical biologists, and offer a set of references that
may be consulted for more informationstor
IAEA Safety Standards for protecting people and the environment
This report presents an analysis of antibacterial agents in preclinical (third annual review) and clinical (fifth annual review) development. The analysis covers traditional (direct-acting small molecules) ... non-traditional antibacterial agents in development worldwide. It evaluates to what extent the present pipeline addresses infections caused by WHO Priority Pathogens, Mycobacterium tuberculosis and Clostridioides difficile. The report also provides an assessment of the traditional agents with respect to whether they meet a set of predefined criteria for innovation, namely absence of known cross-resistance, new target, mode of action and/or class. It also includes an overview of the agents that obtained authorization since 1 July 2017.
Buruli ulcer caused by Mycobacterium ulcerans is a neglected tropical disease characterized by extensive ulceration involving predominantly the upper and lower limbs of patients. The disease is common in rural tropical communities in West ... Central Africa, where access to proper health care is limited. Pathogenesis of the characteristic painless ulcers is linked to the elaboration by M. ulcerans of a lipid toxin called mycolactone that has potent cytopathic, immunosuppressive, and analgesic effects on a host of cells in cutaneous tissues. Mycolactone is known to profoundly inhibit secretion of a plethora of proteins that are essential for wound healing. Even though a combination antibacterial therapy of streptomycin and rifampicin for 8 weeks is effective for treatment, it relies on good and appropriate wound management to prevent secondary bacterial infections and improve healing. Evidence-based interventions for wound care in Buruli ulcer disease are often lacking and have relied on expert advice and recommendations. Surgical interventions are limited to debridement of necrotic tissue and grafting of extensive ulcers, usually after antibiotic therapy. Patients’ rehabilitation is an important component of care to reduce disabilities associated with the disease and proper integration into the community after treatment.
Chagas disease (American trypanosomiasis) is caused by the protozoan parasite Trypanosoma cruzi, and transmitted to humans by infected triatomine bugs, and less commonly by transfusion, organ transp...
Cystic echinococcosis (CE) is a well-known neglected parasitic disease. However, evidence supporting the four current treatment modalities is inadequate, and treatment options remain controversial. The aim of this work is to analyse the available da...
The cardiovascular disease continuum begins with risk factors such as diabetes mellitus (DM), progresses to vasculopathy and myocardial dysfunction, and finally ends with cardiovascular death. Diabe...
The document, "Progress on the Prevention and Control of Non-Communicable Diseases," reports on global efforts to reduce the impact of NCDs, such as heart disease, cancer, diabetes, and chronic resp...
The reader acknowledges that this report is intended as an evidence-based asthma management strategy, for the use of health professionals and policy-makers. It is based, to the best of our knowledge, on current best evidence ... medical knowledge and practice at the date of publication. When assessing and treating patients, health professionals are strongly advised to use their own professional judgment, and to take into account local and national regulations and guidelines. GINA cannot be held liable or responsible for inappropriate healthcare associated with the use of this document, including any use which is not in accordance with applicable local or national regulations or guidelines.
